Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Deal Watch: AbbVie Bets On Turnstone’s Cancer Immunotherapy Technology

Executive Summary

AbbVie takes options on three oncolytic virus immunotherapies under development at Turnstone. Amgen and CytomX swap IP in cancer immunotherapy collaboration, while Nicox and pSivida will team to fight glaucoma and other eye diseases.


Related Content

Amgen Focuses On Pipeline As Mature Products Face Declining Demand
Keeping Track: Flexion's Non-Opioid Knee Pain Drug Gets OK, Botox Gets Another Approval
Cancer-Focused Medivir Licenses AMR Centre Promising Superbug Assets
Siamab, BI Team To ‘Attack’ Potential Of Carbohydrate Antibodies In Cancer
Deal Watch: Are Ultragenyx, REGENXBIO In A Bidding War For Dimension?
Deal Watch: Seattle Genetics Adds To Antibody-Drug Conjugate Portfolio


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts